Tim Delany
@tdelany.bsky.social
Strategy & Partnering @Metabolon
Multiomics | Science | Outdoor life
#metabolomics
https://www.linkedin.com/in/timdelany/
Multiomics | Science | Outdoor life
#metabolomics
https://www.linkedin.com/in/timdelany/
Reposted by Tim Delany
Pharma companies take note - human knockouts in bottleneck and consanguineous populations are up and coming.
Plasma Metabolic Outliers Identified in #Estonian Human Knockouts: www.mdpi.com/2218-1989/15...
citing our #Qatar study with @metabolon.bsky.social data:
www.cell.com/cell-genomic...
Plasma Metabolic Outliers Identified in #Estonian Human Knockouts: www.mdpi.com/2218-1989/15...
citing our #Qatar study with @metabolon.bsky.social data:
www.cell.com/cell-genomic...
November 4, 2025 at 1:16 PM
Pharma companies take note - human knockouts in bottleneck and consanguineous populations are up and coming.
Plasma Metabolic Outliers Identified in #Estonian Human Knockouts: www.mdpi.com/2218-1989/15...
citing our #Qatar study with @metabolon.bsky.social data:
www.cell.com/cell-genomic...
Plasma Metabolic Outliers Identified in #Estonian Human Knockouts: www.mdpi.com/2218-1989/15...
citing our #Qatar study with @metabolon.bsky.social data:
www.cell.com/cell-genomic...
Delighted with this one - a few years in the making! 😄 Great to be partnering with one of the world’s largest health studies to advance precision health through metabolomics. Looking forward to seeing the insights generated from integrating our data with ethnically diverse multiomic data
📢 Press Release:
Metabolon partners with China Kadoorie Biobank (CKB), one of the world's largest and most comprehensive cohort studies, to better understand how genetics, environment, lifestyle, and socioeconomic factors shape chronic diseases in underrepresented populations.
#PrecisionMedicine
Metabolon partners with China Kadoorie Biobank (CKB), one of the world's largest and most comprehensive cohort studies, to better understand how genetics, environment, lifestyle, and socioeconomic factors shape chronic diseases in underrepresented populations.
#PrecisionMedicine
September 10, 2025 at 1:57 PM
Delighted with this one - a few years in the making! 😄 Great to be partnering with one of the world’s largest health studies to advance precision health through metabolomics. Looking forward to seeing the insights generated from integrating our data with ethnically diverse multiomic data
Reposted by Tim Delany
Metabolon extends heartfelt congratulations to Dr. Jessica Lasky-Su on her well-deserved recognition as an Honorary Fellow of the Metabolomics Society. Dr. Lasky-Su has been a pioneering force in the field, advancing our understanding of how metabolic perturbations influence human health outcomes.
June 23, 2025 at 6:48 PM
Metabolon extends heartfelt congratulations to Dr. Jessica Lasky-Su on her well-deserved recognition as an Honorary Fellow of the Metabolomics Society. Dr. Lasky-Su has been a pioneering force in the field, advancing our understanding of how metabolic perturbations influence human health outcomes.
Nice use of poly-metabolite scores for looking at UPFs using @metabolon.bsky.social data.
Tracking consumption of ultra-processed foods via metabolites in blood or urine journals.plos.org/plosmedicine...
Identification and validation of poly-metabolite scores for diets high in ultra-processed food: An observational study and post-hoc randomized controlled crossover-feeding trial
Leila Abar and colleagues use data from an observational study and an RCT to assess poly-metabolites in diets high in ultra-processed food
journals.plos.org
May 20, 2025 at 10:06 PM
Nice use of poly-metabolite scores for looking at UPFs using @metabolon.bsky.social data.
Looking forward to seeing the various research outputs from the new microbiome solution. This product has been in the works for quite some time!
Metabolon is excited to announce the launch of our new Microbiome Research Solution. This comprehensive solution combines metabolomics and metagenomics data generation with multiomic data analysis to provide deeper insights into the microbiome.
Metabolon Launches Microbiome Research Solution Combining New Microbiome Panel, Metagenomics Sequencing, and Multiomics Bioinformatics Tools
The combination of metagenomics and metabolomics data, integrated within an intuitive bioinformatics platform, enables deeper microbiome insights than possible with either approach individually…
mtbln.co
April 29, 2025 at 4:16 PM
Looking forward to seeing the various research outputs from the new microbiome solution. This product has been in the works for quite some time!
Nice paper from Fredrik Backhed's lab looking at the #microbiome in Type 2 Diabetes.
🚨 New research reveals the gut microbiome drives ~30% of blood metabolite variation in T2D! Using Metabolon’s data and machine learning, this study underscores the importance of early microbiome-targeted interventions.
mtbln.co/pi7o4n
mtbln.co/pi7o4n
April 9, 2025 at 2:59 PM
Nice paper from Fredrik Backhed's lab looking at the #microbiome in Type 2 Diabetes.
Reposted by Tim Delany
🧠 🧬A new paper from @harvardmed.bsky.social using Metabolon's data links gut-derived metabolites, especially from the tryptophan pathway, to Multiple Sclerosis inflammation via AHR receptor signaling—unlocking potential new therapeutic targets.
mtbln.co/cg3ozu
#Metabolomics
mtbln.co/cg3ozu
#Metabolomics
Gut microbiota and metabolites are linked to disease progression in multiple sclerosis
Understanding pathobiology at the shift from relapsing to progressive multiple sclerosis
(MS) is critically important. In this study, Schwerdtfeger et al. use a 2-year follow-up
cohort to show that su...
mtbln.co
April 4, 2025 at 5:06 PM
🧠 🧬A new paper from @harvardmed.bsky.social using Metabolon's data links gut-derived metabolites, especially from the tryptophan pathway, to Multiple Sclerosis inflammation via AHR receptor signaling—unlocking potential new therapeutic targets.
mtbln.co/cg3ozu
#Metabolomics
mtbln.co/cg3ozu
#Metabolomics
Interesting paper looking at microbial metabolites' link with Multiple Scelerosis.
Delighted @metabolon.bsky.social could contribute.
Delighted @metabolon.bsky.social could contribute.
The gut microbiome's link with multiple sclerosis www.cell.com/cell-reports...
April 3, 2025 at 8:21 PM
Interesting paper looking at microbial metabolites' link with Multiple Scelerosis.
Delighted @metabolon.bsky.social could contribute.
Delighted @metabolon.bsky.social could contribute.
Interesting new paper from the METSIM & FinnGen, which "uncovered causal effects of plasma metabolites on a broad spectrum of human diseases"
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints - Nature Communications
Metabolites can be used to estimate disease risk. Here, the authors use Mendelian randomization to infer the potential causal effects of 1099 plasma metabolites on the risk of 2099 binary disease endp...
www.nature.com
April 2, 2025 at 10:21 AM
Interesting new paper from the METSIM & FinnGen, which "uncovered causal effects of plasma metabolites on a broad spectrum of human diseases"
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Interesting new publication out on novel biomarker signatures for IBS distinctly seen across sample types.
www.mdpi.com/2218-1989/15...
www.mdpi.com/2218-1989/15...
Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome
Background/Objectives: Irritable bowel syndrome (IBS) is a complex disorder affecting 10% of the global population, but the underlying mechanisms remain poorly understood. By integrating multifluid me...
www.mdpi.com
February 12, 2025 at 3:36 PM
Interesting new publication out on novel biomarker signatures for IBS distinctly seen across sample types.
www.mdpi.com/2218-1989/15...
www.mdpi.com/2218-1989/15...
I'll be in London later this week for this event. Keen to catch-up with old friends and new faces.
#FOG2025
#FOG2025
We are excited to participate in the Festival of Genomics and Biodata 2025, happening in London this week on January 29-30, 2025. Visit us at Booth #116 to discover how metabolomics can provide additional insights to genomics research. mtbln.co/0i03j5
Festival of Genomics and Biodata 2025
mtbln.co
January 27, 2025 at 5:37 PM
I'll be in London later this week for this event. Keen to catch-up with old friends and new faces.
#FOG2025
#FOG2025
Have enjoyed reading other intros here, so figured I'd partake
Currently based out of Dublin, by day I've a keen interest in the potential of multiomics - working on partnerships and collaborations in @metabolon.bsky.social
Outside of work you'll find me somewhere outdoors, most likely the hills!
Currently based out of Dublin, by day I've a keen interest in the potential of multiomics - working on partnerships and collaborations in @metabolon.bsky.social
Outside of work you'll find me somewhere outdoors, most likely the hills!
January 24, 2025 at 4:00 PM
Have enjoyed reading other intros here, so figured I'd partake
Currently based out of Dublin, by day I've a keen interest in the potential of multiomics - working on partnerships and collaborations in @metabolon.bsky.social
Outside of work you'll find me somewhere outdoors, most likely the hills!
Currently based out of Dublin, by day I've a keen interest in the potential of multiomics - working on partnerships and collaborations in @metabolon.bsky.social
Outside of work you'll find me somewhere outdoors, most likely the hills!